Journal of Clinical Endocrinology & Metabolism Vol. 54, No. 6 1097-1100 doi:10.1210/jcem-54-6-1097 Copyright © 1982 by the Endocrine Society. The Extrathyroidal Effect of D,L-Propranolol on 3,3',5'-Triiodothyronine, 3',5'-Diiodothyronine, 3,3'-Diiodothyronine, and 3'-Monoiodothyronine Kinetics*I. B. LUMHOLTZ, J. FABER, C. KIRKEGAARD, K. SIERSBÆK-NIELSEN and T. FRIISDepartments of Internal Medicine E and Clinical Chemistry, Frederiksberg Hospital DK-2000 Copenhagen F, Denmark Address all correspondence and requests for reprints to: Bo Lumholtz, M.D., Department of Internal Medicine E, Frederiksberg Hospital, DK-2000 Copenhagen F, Denmark. The effect of D,L-propranolol (80 mg daily) on the peripheral monodeiodination of rT3, 3',5'-diiodothyronine (3',5'-T2), 3,3'-diiodothyronine (3,3'-T2), and 3'-monoiodothyronine (3'-T1) was studied in seven out-patients with severe pretreatment hypothyroidism. The patients were maintained euthyroid on a constant L-T4 replacement therapy. A bolus injection technique was used; MCR, production rate (PR), and conversion rate were determined using a noncompartmental kinetic model. During D,L-propranolol, serum rT3 and 3',5'-T2 increased (P < 0.02), and 3,3'-T2 seemed to decrease. The MCRs of rT3, 3',5'-T2, and 3,3'-T2 (P < 0.02) decreased during drug treatment. The MCR and PR of 3'-T1 were reduced, albeit not significantly (P < 0.10). The PR of 3,3'-T2 was reduced (P < 0.02), whereas the PRs of rT3 and 3',5'-T2 were unaltered. The conversion rate of rT3 to 3',5'-T2 was unaltered. No changes were seen in the apparent distribution volumes of the iodothyronines studied. The results are compatible with the assumption that D,L-propranolol, or a metabolite thereof, inhibits the 5'-deiodination of all of the iodothyronines. (J Clin Endocrinol Metab 54: 1097, 1982)
* This work was supported by the Danish Hospital Foundation for Medical Research, Region of Copenhagen, the Farae Islands, and Greenland and The Danish Medical Research Council. Received March 5, 1981.
|